CD200 and tuberous sclerosis: In the present study, we provided the first evidence of cell-specific downregulation of both mRNA and protein levels of CD200 in epileptogenic lesions of FCD IIb and TSC patients, while the expression of its receptor, CD200R, was not significantly changed.